CAPA E LOMBADA - Arca - Fiocruz

104
INHRR (Instituto Nacional de Higiene Rafael Rangel). Anexo a las Normas de la
Junta Revisora de Productos Farmacéuticos: Proyecto de Norma de los
Productos Biologicos. Caracas; 2008.
INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos).
Normatividad Medicamentos. [online]. Bogotá, Colômbia; 2009 [capturado 19
jan 2009]. Disponível em:
http://www.invima.gov.co/Invima//normatividad/medicamentos.jsp?codigo=182
Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond
Ser B 1957; 147: 258-267.
Janeway CA, Travers P, Walport M, Shlomchik M. Imunobiologia – O sistema
imune na saúde e na doença. 5 ed. Porto Alegre: Artmed; 2002.
Jenner E. An inquiry into the causes and effects of the variole vaccine, a
disease discovered in some of the western counties of England, particularly
Gloucestershire, and known by the name of The Cow Pox. 2 ed. London:
Sampson Low; 1800.
Kim L. Imitation to innovation – the dynamics of Korea’s technological learning.
Boston: Harvard Business School; 1997.
Koenig GL. Viability of and Plasmid Retention in Frozen Recombinant
Escherichia coli over Time: a Ten-Year Prospective Study. Appl Environ
Microbiol 2003; 69 (11): 6605-6609.
Koren E, Zuckerman LA, Mire-Sluis AR. Immune responses to therapeutic
proteins in humans – clinical significance, assessment and prediction. Curr
Pharm Biotechnol 2002; 3 (4): 349-360.
Kovarik P, Sauer I, Schaljo B. Molecular mechanisms of the anti-inflammatory
functions of interferons. Immunobiology 2008; 212 (9-10): 895-901.
Krause CD, Pestka S. Evolution of the Class 2 cytokines and receptors, and
discovery of new friends and relatives. Pharmacol Ther 2005; 106 (3): 299-
346.
Krieger N, Steiner W, Mitchell D. Frontiers in biocatalysis. Food Technol
Biotechnol 2004; 42(4): 219-221.